Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
France
(961/week)
Czechia
(473/week)
Poland
(348/week)
Germany
(329/week)
Italy
(323/week)
View all
(3,938/week)
News
United States
(407/week)
Manufacturing
(270/week)
Energy
(207/week)
Technology
(312/week)
Professional Services
(116/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Aromatic amines
Jun 01, 2020
New Analysis Confirms That Multiple Myeloma Patients in the OCEAN Study Stay on Treatment Longer Than Previously Estimated - Results Expected H1-2021
May 22, 2020
Oncopeptides Completes Enrollment to the Pivotal Phase 3 Study OCEAN for Relapsed Refractory Multiple Myeloma - 450 Patients Included
Apr 23, 2020
New Early Breast Cancer Drug Available Now In Singapore
Apr 13, 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Mar 02, 2020
FDA Approves New Therapy for Patients with Previously Treated Multiple Myeloma
Mar 02, 2020
FDA Approves New Therapy for Patients with Previously Treated Multiple Myeloma
Mar 02, 2020
FDA Approves New Therapy for Patients with Previously Treated Multiple Myeloma
Mar 02, 2020
FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma
Mar 02, 2020
FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma
Mar 02, 2020
FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma
Feb 12, 2020
ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL
Dec 10, 2019
DARZALEX® (Daratumumab) Regimen Shows Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Dec 07, 2019
Oncopeptides Presents Updated Efficacy and Safety Data from Pivotal Phase 2 HORIZON Study in Patients With RRMM at ASH Annual Meeting 2019
Dec 04, 2019
First Industry Datasets Submitted to ASH Research Collaborative Data Hub
Dec 02, 2019
New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority
Sep 26, 2019
Janssen Announces U.S. FDA Approval of DARZALEX® (daratumumab) Combination Regimen for Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma
Sep 26, 2019
Patient Recruitment in the Pivotal Phase 2-Study HORIZON Completed
Sep 12, 2019
Amgen Highlights New Data From KYPROLIS® (carfilzomib) And Oncology Pipeline At IMW 2019
Aug 16, 2019
Oncopeptides Announces Acceptance of Data for Presentation at International Myeloma Workshop, September 12-15
Jul 12, 2019
Janssen Submits Application to U.S. FDA Seeking Approval of New DARZALEX® (daratumumab) Subcutaneous Formulation
Page 1
››
Latest News
Dec 3, 2023
L'opérateur du satellite espion nord-coréen livrera ses données à l'armée
Dec 3, 2023
HII’s Ingalls Shipbuilding Christens Amphibious Assault Ship Bougainville (LHA 8)
Dec 3, 2023
Women We Admire Announces Top 50 Women Leaders of Arlington for 2023
Dec 2, 2023
Ascend atteint une étape importante en matière de réduction des GES
Dec 2, 2023
Ascend atinge marco de abatimento de gases do efeito estufa
Dec 2, 2023
India Agricultural Machinery Export Market Report 2023-2028: State-Specific Plans and Nodal Agencies Boost...
Dec 2, 2023
M.D.C. HOLDINGS' PRESENTATION AT THE RAYMOND JAMES TMT AND CONSUMER CONFERENCE TO BE WEBCAST LIVE
Dec 2, 2023
Grinding Machinery Market size to increase by USD 1.61 billion during 2023-2028, Growth in the global...
View all News
Agenda
27
February
United Kingdom
Ashton Gate Stadium, Bristol, UK
Europe's Premier Additive Manufacturing for Aerospace, Defence and Space Conference, 27 - 28 February 2024, Ashton Gate Stadium, Bristol, UK
WIDENING THE ADOPTION OF AM IN ADVANCED MANUFACTURING The Additive Manufacturing for Aerospace, Defence & Space...
View All Events